{
  "_originalData": {
    "identity": {
      "bacteriumName": "Chlamydia trachomatis",
      "aliases": [],
      "lastUpdated": "2025-02-03",
      "clsiCategory": "Not classified by CLSI",
      "classification": {
        "gramStain": "Not applicable (does not Gram stain)",
        "morphology": "Coccobacillus",
        "respiration": "Aerobic",
        "notes": [
          "Obligate intracellular bacterium"
        ]
      },
      "strainDetails": [
        {
          "type": "Serovar Group",
          "value": "A, B, Ba, C",
          "notes": "Cause trachoma, a chronic keratoconjunctivitis."
        },
        {
          "type": "Serovar Group",
          "value": "D-K",
          "notes": "Cause urogenital syndromes like urethritis and cervicitis."
        },
        {
          "type": "Serovar Group",
          "value": "L1-L3",
          "notes": "Cause Lymphogranuloma venereum (LGV)."
        }
      ],
      "biochemicalTests": "Obligate intracellular bacterium; cannot be Gram-stained or cultured on standard media. Diagnosis relies on NAATs."
    },
    "clinicalProfile": {
      "summary": "Chlamydia trachomatis is the most common reportable bacterial sexually transmitted infection in the U.S. It causes a variety of clinical syndromes depending on the serovar, including urogenital infections (urethritis, cervicitis, PID), lymphogranuloma venereum (LGV), and trachoma, the leading infectious cause of blindness worldwide.",
      "pathophysiologyPearls": [
        "As an obligate intracellular parasite, C. trachomatis infects epithelial cells, leading to inflammation and tissue damage.",
        "Many infections, particularly in women, are asymptomatic, which facilitates transmission and can lead to long-term complications like infertility if untreated."
      ],
      "keySignsAndSymptoms": [
        "Urethral or cervical discharge",
        "Dysuria",
        "Pelvic pain",
        "Proctitis symptoms (rectal pain, discharge, tenesmus)",
        "Painful inguinal lymphadenopathy (LGV)",
        "Conjunctivitis and corneal scarring (Trachoma)"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Urogenital Infections (Serovars D-K)",
          "description": "Includes cervicitis, urethritis, and pelvic inflammatory disease (PID). Often asymptomatic."
        },
        {
          "syndromeName": "Lymphogranuloma Venereum (LGV) (Serovars L1-L3)",
          "description": "A systemic STI characterized by a transient genital ulcer followed by painful inguinal and/or femoral lymphadenopathy (buboes)."
        },
        {
          "syndromeName": "Trachoma (Serovars A, B, Ba, C)",
          "description": "A chronic keratoconjunctivitis endemic in resource-poor regions, leading to corneal scarring and blindness if untreated."
        },
        {
          "syndromeName": "Neonatal Infections",
          "description": "Can cause ophthalmia neonatorum (conjunctivitis) or pneumonia in infants born to infected mothers."
        }
      ],
      "highRiskPopulations": [
        "Sexually active individuals <25 years old",
        "Men who have sex with men (MSM)",
        "Individuals with new or multiple sexual partners",
        "Residents of or travelers to trachoma-endemic regions"
      ],
      "transmissionVectors": [
        "Sexual contact (urogenital, anal, oral)",
        "Perinatal transmission from mother to infant",
        "Flies and direct contact with ocular/nasal secretions (Trachoma)"
      ],
      "prognosisNotes": [
        "Untreated urogenital infections can lead to PID, ectopic pregnancy, and infertility in women.",
        "Re-infection is common; re-screening 3 months after treatment is recommended."
      ]
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [],
      "majorMechanisms": [],
      "clinicalAlerts": [
        {
          "alertTitle": "Treatment Failures",
          "details": "Clinical failures are reported, and some studies suggest they are more common with single-dose azithromycin compared to a 7-day course of doxycycline, especially for rectal infections."
        },
        {
          "alertTitle": "Persistent State",
          "details": "Exposure to penicillin-class antibiotics (e.g., amoxicillin in pregnancy) may induce a persistent, non-replicative state in the organism, potentially affecting treatment efficacy."
        }
      ]
    },
    "treatment": {
      "generalNotes": [
        "Doxycycline 100 mg PO BID for 7 days is the preferred regimen for most uncomplicated urogenital infections per 2021 CDC STI guidelines.",
        "LGV requires a longer duration of treatment (3 weeks).",
        "Treatment of all sexual partners from the preceding 60 days is recommended (Expedited Partner Therapy - EPT)."
      ],
      "drugsToAvoid": [
        {
          "drugOrClass": "Doxycycline, Fluoroquinolones",
          "condition": "Pregnancy",
          "reason": "Potential fetal harm."
        }
      ],
      "adjunctiveTherapies": [],
      "regimens": [
        {
          "context": {
            "type": "Directed",
            "condition": "Urethritis, Cervicitis, Proctitis (uncomplicated)",
            "patientPopulation": [
              "General"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "7 days",
                  "drugs": [
                    {
                      "drugName": "Doxycycline",
                      "dose": "100 mg",
                      "route": "PO",
                      "frequency": "BID",
                      "comments": "Preferred regimen."
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "Single dose",
                  "drugs": [
                    {
                      "drugName": "Azithromycin",
                      "dose": "1 g",
                      "route": "PO",
                      "frequency": "once",
                      "comments": "Less effective for rectal infections."
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Urogenital Infection in Pregnancy",
            "patientPopulation": [
              "Pregnant women"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "Single dose",
                  "drugs": [
                    {
                      "drugName": "Azithromycin",
                      "dose": "1 g",
                      "route": "PO",
                      "frequency": "once",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "7 days",
                  "drugs": [
                    {
                      "drugName": "Amoxicillin",
                      "dose": "500 mg",
                      "route": "PO",
                      "frequency": "TID",
                      "comments": "May induce a persistent state in the organism."
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        }
      ]
    },
    "laboratoryProfile": {
      "testingIndications": [
        "Annual screening for all sexually active women <25 years.",
        "Screening for older women and MSM with risk factors.",
        "Evaluation of individuals with symptoms of STI (e.g., discharge, dysuria, pelvic pain).",
        "Evaluation of neonates with conjunctivitis or pneumonia."
      ],
      "methodologyNotes": [
        "NAATs are the most sensitive tests for diagnosing C. trachomatis infections.",
        "NAATs cannot distinguish between different serovars (e.g., D-K vs. L1-L3); PCR genotyping is required for this purpose.",
        "NAATs can remain positive for up to 3 weeks after successful treatment due to the detection of non-viable organisms."
      ],
      "recommendedPanel": [
        "Nucleic Acid Amplification Test (NAAT)"
      ],
      "specialTests": [
        {
          "testName": "PCR Genotyping",
          "trigger": "Clinical suspicion of LGV",
          "purpose": "To differentiate LGV serovars (L1-L3) from non-LGV serovars (D-K)."
        }
      ],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "Diagnosis is primarily by NAAT on first-catch urine or swabs from the affected site (cervix, urethra, rectum, pharynx). Vaginal swabs (patient- or clinician-collected) are also highly sensitive.",
        "biosafetyWarning": "Standard precautions are sufficient for handling clinical specimens.",
        "methods": [
          {
            "methodName": "NAAT",
            "details": "The gold standard for diagnosis due to high sensitivity and specificity. Can be performed on various specimen types."
          }
        ]
      },
      "preventionAndScreening": [
        {
          "type": "Screening",
          "details": "Annual screening is recommended for all sexually active women aged <25 years, as well as older women with risk factors (e.g., new or multiple sex partners). Screening of MSM is also advisable.",
          "targetPopulation": "Sexually active women <25, at-risk older women, MSM."
        }
      ],
      "treatmentLifecycle": [
        {
          "topic": "Test of Cure",
          "details": "Not routinely recommended, except in pregnancy. NAAT can remain positive for 2-3 weeks post-treatment."
        },
        {
          "topic": "Retesting for Re-infection",
          "details": "Recommended for all treated individuals 3 months after treatment to detect re-infection."
        },
        {
          "topic": "Partner Treatment",
          "details": "All sexual contacts within the 60 days prior to diagnosis or symptom onset should be tested and treated. Expedited Partner Therapy (EPT) is an option."
        }
      ],
      "antimicrobialStewardship": [
        "Doxycycline for 7 days is more effective than single-dose azithromycin for rectal chlamydial infections."
      ],
      "drugSpecificPearls": [],
      "guidelineReferences": [
        {
          "source": "CDC",
          "citation": "MMWR Recomm Rep 70 (RR-4):1 2021",
          "summaryOrNote": "2021 CDC STI Treatment Guidelines."
        },
        {
          "source": "N Engl J Med",
          "citation": "2017;376:765",
          "summaryOrNote": "Review on screening for Chlamydia trachomatis."
        },
        {
          "source": "Clin Infect Dis",
          "citation": "2019;69:1946",
          "summaryOrNote": "Study on azithromycin efficacy in rectal infections."
        },
        {
          "source": "Clin Infect Dis",
          "citation": "2021;73:824",
          "summaryOrNote": "RCT showing doxycycline is more effective for rectal chlamydia in MSM."
        }
      ]
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.369Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Chlamydia trachomatis"
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": []
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2025-02-03"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Not applicable (does not Gram stain)",
        "morphology": "Coccobacillus",
        "respiration": "Aerobic",
        "notes": [
          "Obligate intracellular bacterium"
        ]
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "Chlamydia trachomatis is the most common reportable bacterial sexually transmitted infection in the U.S. It causes a variety of clinical syndromes depending on the serovar, including urogenital infections (urethritis, cervicitis, PID), lymphogranuloma venereum (LGV), and trachoma, the leading infectious cause of blindness worldwide.",
      "pathophysiologyPearls": [
        "As an obligate intracellular parasite, C. trachomatis infects epithelial cells, leading to inflammation and tissue damage.",
        "Many infections, particularly in women, are asymptomatic, which facilitates transmission and can lead to long-term complications like infertility if untreated."
      ],
      "keySignsAndSymptoms": [
        "Urethral or cervical discharge",
        "Dysuria",
        "Pelvic pain",
        "Proctitis symptoms (rectal pain, discharge, tenesmus)",
        "Painful inguinal lymphadenopathy (LGV)",
        "Conjunctivitis and corneal scarring (Trachoma)"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Urogenital Infections (Serovars D-K)",
          "description": "Includes cervicitis, urethritis, and pelvic inflammatory disease (PID). Often asymptomatic."
        },
        {
          "syndromeName": "Lymphogranuloma Venereum (LGV) (Serovars L1-L3)",
          "description": "A systemic STI characterized by a transient genital ulcer followed by painful inguinal and/or femoral lymphadenopathy (buboes)."
        },
        {
          "syndromeName": "Trachoma (Serovars A, B, Ba, C)",
          "description": "A chronic keratoconjunctivitis endemic in resource-poor regions, leading to corneal scarring and blindness if untreated."
        },
        {
          "syndromeName": "Neonatal Infections",
          "description": "Can cause ophthalmia neonatorum (conjunctivitis) or pneumonia in infants born to infected mothers."
        }
      ],
      "highRiskPopulations": [
        "Sexually active individuals <25 years old",
        "Men who have sex with men (MSM)",
        "Individuals with new or multiple sexual partners",
        "Residents of or travelers to trachoma-endemic regions"
      ],
      "transmissionVectors": [
        "Sexual contact (urogenital, anal, oral)",
        "Perinatal transmission from mother to infant",
        "Flies and direct contact with ocular/nasal secretions (Trachoma)"
      ],
      "prognosisNotes": [
        "Untreated urogenital infections can lead to PID, ectopic pregnancy, and infertility in women.",
        "Re-infection is common; re-screening 3 months after treatment is recommended."
      ]
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [],
      "majorMechanisms": [],
      "clinicalAlerts": [
        {
          "alertTitle": "Treatment Failures",
          "details": "Clinical failures are reported, and some studies suggest they are more common with single-dose azithromycin compared to a 7-day course of doxycycline, especially for rectal infections."
        },
        {
          "alertTitle": "Persistent State",
          "details": "Exposure to penicillin-class antibiotics (e.g., amoxicillin in pregnancy) may induce a persistent, non-replicative state in the organism, potentially affecting treatment efficacy."
        }
      ]
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": [
        {
          "regimenId": "modern-0-0-0",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Urethritis, Cervicitis, Proctitis (uncomplicated)",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Doxycycline",
              "dose": "100 mg",
              "route": "PO",
              "frequency": "BID",
              "duration": "7 days",
              "comments": "Preferred regimen.",
              "originalText": "Doxycycline 100 mg PO BID"
            }
          ]
        },
        {
          "regimenId": "modern-0-1-0",
          "extractedFrom": "treatment.regimens[0].recommendations[1].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Urethritis, Cervicitis, Proctitis (uncomplicated)",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Azithromycin",
              "dose": "1 g",
              "route": "PO",
              "frequency": "once",
              "duration": "Single dose",
              "comments": "Less effective for rectal infections.",
              "originalText": "Azithromycin 1 g PO once"
            }
          ]
        },
        {
          "regimenId": "modern-1-0-0",
          "extractedFrom": "treatment.regimens[1].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Urogenital Infection in Pregnancy",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Pregnant women"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Azithromycin",
              "dose": "1 g",
              "route": "PO",
              "frequency": "once",
              "duration": "Single dose",
              "comments": "",
              "originalText": "Azithromycin 1 g PO once"
            }
          ]
        },
        {
          "regimenId": "modern-1-1-0",
          "extractedFrom": "treatment.regimens[1].recommendations[1].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Urogenital Infection in Pregnancy",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Pregnant women"
              ],
              "labFindings": null
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Amoxicillin",
              "dose": "500 mg",
              "route": "PO",
              "frequency": "TID",
              "duration": "7 days",
              "comments": "May induce a persistent state in the organism.",
              "originalText": "Amoxicillin 500 mg PO TID"
            }
          ]
        }
      ]
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [
        "Annual screening for all sexually active women <25 years.",
        "Screening for older women and MSM with risk factors.",
        "Evaluation of individuals with symptoms of STI (e.g., discharge, dysuria, pelvic pain).",
        "Evaluation of neonates with conjunctivitis or pneumonia."
      ],
      "methodologyNotes": [
        "NAATs are the most sensitive tests for diagnosing C. trachomatis infections.",
        "NAATs cannot distinguish between different serovars (e.g., D-K vs. L1-L3); PCR genotyping is required for this purpose.",
        "NAATs can remain positive for up to 3 weeks after successful treatment due to the detection of non-viable organisms."
      ],
      "recommendedPanel": [
        "Nucleic Acid Amplification Test (NAAT)"
      ],
      "specialTests": [
        {
          "testName": "PCR Genotyping",
          "trigger": "Clinical suspicion of LGV",
          "purpose": "To differentiate LGV serovars (L1-L3) from non-LGV serovars (D-K)."
        }
      ],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}